Alok Swaroop

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Ejection Fraction

Top Venues

American journal of hematology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology (2024)
Jia Ruan, Jasmine M Zain, Brett Palmer, Borko Jovanovic, Xinlei Mi, Alok Swaroop, Jane N Winter, Leo I Gordon, Reem Karmali, Jonathan Moreira, Adam M Petrich, Barbara Pro
Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma. Blood advances (2023)
Jianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, Crissandra Piper, Daphne Dupere-Richer, Jacob S Roth, Duohui Jing, Heidi L Casellas Roman, Catalina Troche, Alok Swaroop, Marta Kulis, Jon A Oyer, Christine M Will, Min Shen, Alberto Riva, Richard L Bennett, Adolfo A Ferrando, Matthew D Hall, Richard B Lock, Jonathan D Licht
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia. Cancer discovery (2021)